Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0YJ5H
|
||||
Former ID |
DIB001646
|
||||
Drug Name |
EX-1311
|
||||
Synonyms |
EX-1311; EX-1350; EX-1365; EX-1832; EX-51; Ghrelin antagonists (metabolic disease); Ghrelin antagonists (metabolic disease), Elixir; Ghrelin antagonists (metabolic disease), Elixir/Novartis
|
||||
Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Investigative | [543633] | ||
Company |
Elixir Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(CCN(CC)CC)S(=O)(=O)N[C@H](CCc1ccccc1)c1[nH]nc(n1)c1cc<br />c(cc1)OC
|
||||
Target and Pathway | |||||
Target(s) | Growth hormone secretagogue receptor type 1 | Target Info | Antagonist | [543633] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.